Devastating and persistent neurological deficits occur after Spinal Cord Injury (SCI), despite survival of nearly all neurons. The primary cause of disability is disconnection of networks by axon transection. Recovery of some movement would be adequate for patients to gain a level of independence in wheel chair transfers, bowel and bladder management, and locomotion. Today, there is no approved medical therapy for the 300,000 to 1,200,000 individuals in the USA with SCI. The CNS of adult mammals, as compared to the peripheral nervous system of mammals or the nervous system of other organisms, has extremely limited capacity for axonal regeneration. Our axonal growth studies included discovery of Nogo and Nogo Receptor (NgR1). We demonstrated their role in preventing axonal sprouting, regeneration and recovery after injury. We have demonstrated that NgR1(310)-Fc is efficacious for recovery from SCI, even when treatment starts months after damage. It is being developed for human SCI trials now. While specific factors, such as NgR1, limiting axon regeneration have been identified, they provide an incomplete explanation for poor adult mammalian CNS regeneration. We completed a genome-wide shRNA screen for endogenous genes limiting mammalian CNS axon repair. The validity of this method was demonstrated by the identification of INPP5F as a gene limiting neural repair in a pilot screen of phosphatases. One cellular pathway is bioinformatically the most enriched gene set in the mammalian screen, and also regulates regeneration in nematodes. The relevance of this pathway will be tested in preclinical models of traumatic SCI. Both gene deletion strains and pharmacological inhibition will be studied to provide a validated pathway for future therapeutic development. The findings will have high relevance for the development of novel therapeutics for SCI.

Public Health Relevance

Many neurological conditions disrupt connections between surviving neurons. The regeneration of axons has the potential to provide functional neurological recovery, without requiring ?new? cells from transplantation or from neurogenesis. Unfortunately, the CNS of adult mammals, as compared to the peripheral nervous system or nervous system of other organisms, has extremely limited capacity for axon regeneration. We have developed screening methods to identify those genes limiting the repair of axons in the mammalian CNS. We will evaluate regeneration-limiting genes using model organisms, biochemical methods and translational models of traumatic spinal cord injury.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Unknown (R35)
Project #
Application #
Study Section
Special Emphasis Panel (ZNS1)
Program Officer
Bambrick, Linda Louise
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Schools of Medicine
New Haven
United States
Zip Code
Kostylev, Mikhail A; Tuttle, Marcus D; Lee, Suho et al. (2018) Liquid and Hydrogel Phases of PrPC Linked to Conformation Shifts and Triggered by Alzheimer's Amyloid-? Oligomers. Mol Cell 72:426-443.e12
Sekine, Yuichi; Lin-Moore, Alexander; Chenette, Devon M et al. (2018) Functional Genome-wide Screen Identifies Pathways Restricting Central Nervous System Axonal Regeneration. Cell Rep 23:415-428
Strittmatter, Stephen M (2018) Emerging Mechanisms in Alzheimer's Disease and Their Therapeutic Implications. Biol Psychiatry 83:298-299
Sekine, Yuichi; Siegel, Chad S; Sekine-Konno, Tomoko et al. (2018) The nociceptin receptor inhibits axonal regeneration and recovery from spinal cord injury. Sci Signal 11:
Salazar, Santiago V; Cox, Timothy O; Lee, Suho et al. (2018) Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-? Induced Synaptic Dysfunction and Loss. J Neurosci :
Huebner, Eric A; Budel, St├ęphane; Jiang, Zhaoxin et al. (2018) Diltiazem Promotes Regenerative Axon Growth. Mol Neurobiol :
Brody, A Harrison; Strittmatter, Stephen M (2018) Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5. Adv Pharmacol 82:293-323
Smith, Levi M; Zhu, Rong; Strittmatter, Stephen M (2018) Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model. Neuropharmacology 130:54-61
Dell'Anno, Maria Teresa; Wang, Xingxing; Onorati, Marco et al. (2018) Human neuroepithelial stem cell regional specificity enables spinal cord repair through a relay circuit. Nat Commun 9:3419
Salazar, Santiago V; Gallardo, Christopher; Kaufman, Adam C et al. (2017) Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease. J Neurosci 37:9207-9221

Showing the most recent 10 out of 23 publications